Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress

Table 2

Analysis of relative biochemical indicators.

Group	Control group	Prediabetes groups	Newly diagnosed type 2 diabetes group	𝐹/𝜒^2 value	𝑃 value
Number of patients (M/F)	33 (12/21)	33 (12/21)	43 (25/18)
FPG	5.43±0.45	6.08±0.53	7.54±1.17	72.87^a	<.001*
PPG	6.49±0.89	8.80±1.09	14.55±3.19	90.78^a	<.001*
DPG	1.19±0.59	2.72±1.31	7.01±2.45	78.85^a	<.001*
HbA1C (%)	5.96±0.31	6.50±0.01	7.40±0.97	67.02^a	<.001*
GA	12.73±1.00	13.71±0.93	16.59±1.81	75.93^a	<.001*
TC	5.48±0.55	5.52±0.97	5.84±1.74	2.44^a	.296
TG	1.51±0.49	1.80±0.90	2.16±1.17	5.78^a	.056
LDL-C	3.07±0.61	3.14±0.75	3.23±0.71	0.48	.618
HDL-C	1.36±0.39	1.24±0.26	1.17±0.26	6.27^a	.043**
HOMA-IRI	1.85±1.43	2.69±2.15	3.48±2.74	7.68^a	.022**
HOMA-β	80.49±59.30	81.45±66.45	52.99±41.58	5.35^a	.069

FPG: fasting plasma glucose; PPG: postprandial plasma glucose; DPG: diphosphoglycerate plasma glucose; HbA₁C: glycosylated haemoglobin; GA: glycated albumin; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IRI: homeostasis model method of assessment-insulin resistance index; HOMA-β: homeostasis model method of assessment β-cell function.
^aNonparametric analysis method used.
*Significant among the 3 groups.
**Significant between newly diagnosed type 2 diabetes and control group.